Clinical Trial Update: Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and tolerability of an ovarian stimulation protocol combining follicle-stimulating hormone (FSH) with degarelix a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Invasive Ductal Carcinoma of the Breast

Drugs mentioned

• Firmagon (Degarelix)
• follicle-stimulating hormone (follicle-stimulating hormone)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Invasive Ductal Breast Carcinoma | Phase 2 | Status: COMPLETED